4D Molecular Therapeutics Inc
FDMT
Health Care
2
exclusion reasons
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
4D Molecular Therapeutics is a biotechnology company whose core business model involves the development of gene therapy products. This process requires extensive animal testing to meet regulatory requirements for safety and efficacy. The company’s pipeline, including candidates for conditions like wet age-related macular degeneration and Fabry disease, relies on preclinical data generated from animal models.
While specific violation records for 4D Molecular Therapeutics are not cited in the provided evidence, the company operates within an industry sector where animal testing is a standard, integral component of product development. Broader industry audits, such as the 2025 report compiling hundreds of welfare violations from U.S. laboratories, indicate systemic animal suffering is a prevalent risk in biomedical research. The company’s business is built on a research and development pathway that inherently exploits animals at scale.
4D Molecular Therapeutics is a clinical-stage biotechnology company developing gene therapies for rare diseases. Its product development pipeline requires preclinical animal studies as part of the regulatory pathway for FDA approval. The company's SEC filings routinely reference the completion of these animal studies as a standard step in its research process. As a biopharmaceutical company whose core business is advancing novel drug candidates, 4D Molecular Therapeutics relies on animal testing to generate safety and efficacy data for its clinical trials.
Research Sources
9 organizations
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.